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It is clinically and theoretically plausible that insomnia contributes to the development and maintenance
of paranoid fears. The primary aim of the study was to establish in a large sample whether insomnia and
paranoia are associated more strongly than by chance. Cross-sectional data on paranoia, insomnia,
anxiety, worry, depression, irritability, and cannabis use were obtained from the second British National
Survey of Psychiatric Morbidity, a general population survey of adults aged 16e74 years living in Great
Britain (N ¼ 8580). It was found that insomnia was associated with an approximately two to threefold
increase in paranoid thinking. Paranoia and insomnia were both strongly associated with the presence of
anxiety, worry, depression, irritability and cannabis use. In a path analysis the association of paranoia and
insomnia was partially explained by the affective symptoms, and, to a much lesser degree, cannabis use.
The results are consistent with recent developments in the cognitive understanding of persecutory
delusions, in which insomnia, negative affect, and substance use are identiﬁed as key factors. Longitu-
dinal studies of insomnia and paranoia, and tests of the effects of sleep interventions on levels of
paranoia, are now required to examine causality.
 2010 Elsevier Ltd. Open access under CC BY license. 1. Introduction
Difﬁculties in falling or staying asleep are common. Approxi-
mately 30% of the general population experience current symptoms
of insomnia, with a third of this group having chronic insomnia
(Ohayon, 2002;Walsh, 2004;Morin et al., 2006; Stewart et al., 2006).
It is only in the last few years that it has been recognised that
paranoid thinking is almost as prevalent. At least 25% of the general
public regularly experience paranoid thoughts, and the lifetime
prevalence of persecutory delusions is approximately 5% (Freeman
and Freeman, 2008; Rutten et al., 2008). Intriguingly, both
insomnia and paranoia have been linked with negative affect. Sleep
difﬁculties are a risk factor for developing emotional disorders such
as anxiety and depression (Ford and Kamerow, 1989; Breslau et al.,
1996; Morphy et al., 2007), while negative affective states predict
the occurrence of paranoid thinking (see Freeman, 2007; Bentallman).
 license. et al., 2008). Therefore insomnia exacerbates factors shown in
separate research to predict paranoia. It is plausible that sleep
difﬁculties contribute to the occurrence of paranoia. An unfortunate
direct example of this can be seen in a treatment case series where
sleep deprivation for 36 h led to a worsening of delusions in indi-
viduals with depressive psychosis (Benedetti et al., 1999).
Sleep difﬁculties have been noted in people with schizophrenia,
for example as a common prodromal symptom (Birchwood et al.,
1989; Yung and McGorry, 1996), but only one study has directly
examined insomnia and paranoia. In 300 individuals from the
general population, insomnia and paranoid ideation were strongly
associated, and the associationwas partly explained by the presence
of anxiety and depression (Freeman et al., 2009). In a small group of
patients with persecutory delusions (and a diagnosis of schizo-
phrenia), moderate or severe insomnia was present in more than
50%. This provides preliminary evidence of the potential importance
of insomnia for understanding paranoia. The central aim of the
current study is to corroborate this association by examining data
from the British National Survey of Psychiatric Morbidity (2000)
(Singleton et al., 2001a), a large population-based survey with
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insomnia is associated with paranoia. A secondary prediction is that
the association will be partly explained by levels of negative affect
and associated experiences (anxiety, worry, depression, and irrita-
bility). When attempting to account for the potential association it is
relevant to note that substance use has been separately linked to
sleep difﬁculties (e.g. Roth et al., 2006; Stein et al., 2008; Shibley
et al., 2008) and to delusions (e.g. Henquet et al., 2008; Morrison
et al., 2009; Johns et al., 2004); therefore a mediational role for
cannabis use in an association of insomnia and paranoia is also
scrutinised. However it is important to highlight that causal rela-
tionships cannot be determined in this cross-sectional study.
2. Method
The second British National Survey of Psychiatric Morbidity was
carried out between March and September 2000. Adults aged
16e74 years and living in private households in Great Britain were
sampled. The data used in this study are based on interviews
carried out by experienced Ofﬁce of National Statistics (ONS)
interviewers. More details of the topics covered and the methods
used are given by Singleton et al., (2001a,b).
2.1. Participants
A stratiﬁed multi-stage random probability sample was used.
There were two stages in the sample selection e the sampling of the
primary sampling units (PSUs), followed by the sampling of
addresses within the selected PSUs. The PSUs were individual or
grouped postcode sectors. In the ﬁrst stage of sampling, the postcode
sectors were stratiﬁed on the basis of a measure of socioeconomic
status within a regional breakdown. First, postcode sectors were
divided into regions based on NHS Regional Ofﬁce. All the PSUs
within each regional stratum were then further stratiﬁed on the
basis of the proportion of household heads in socioeconomic groups
1e5 and 13, and sorted by the proportion of households without
a car based on 1991 census data. The postal sectors (the primary
sampling units) were then sampled from each stratumwith a prob-
ability proportional to size (i.e. the number of delivery points). In this
way a total of 438 postal sectors was selected. In the second stage of
the sampling, 36 addresses were randomly selected within each of
the selected postal sectors. This yielded a total sample of 15,804
addresses. Interviewers visited these to identify private households
with at least one person aged 16e74 years. One person was selected
from each qualifying household using the Kish (1965) grid method.
Just under 70% of those approached agreed to a ﬁrst phase interview,
which the vast majority completed in full (8580: 95%).
2.2. Assessments
The current study uses data from three survey instruments: the
Clinical Interview Schedule Revised (CIS-R e Lewis et al., 1992), the
Psychosis Screening Questionnaire (PSQ; Bebbington and Nayani,
1995), and the self-completion (screening) questionnaire version
of the Structured Clinical Interview for DSM-IV (SCID-II; First et al.,
1997). The complete list of questions used in the survey is available
on the Internet (www.statistics.gov.uk/downloads/theme_health/
PMA_2000_AppB.pdf).
Sleep problems were assessed using the CIS-R (Lewis et al.,
1992). Insomnia was deﬁned in three ways:
I1. Sleep difﬁculties: problems in the past month with trying to
get to sleep or with getting back to sleep (item D1).
I2. Insomnia of at least moderate severity: problems in the past
month with trying to get to sleep or with getting back tosleep, occurring at least four nights in the past week, and
taking at least 1 h to attain sleep on an evening in the past
week (items D1, D3, D5).
I3. Chronic insomnia: sleep problems for at least six months,
problems with trying to get to sleep or with getting back to
sleep, occurring at least four nights in the past week, taking at
least 1 h to attain sleep on an evening in the past week,
together with reports of tiredness (items D1, D3, D5, D10, B1).
Persecutory ideation was also examined in three ways:
P1. Endorsement of the PSQ item ‘In the past year, have there been
times when you felt that people were deliberately acting to
harm you or your interests?’
P2. Endorsement of the PSQ item ‘In the past year, have there been
times you felt that a group of people was plotting to cause you
serious harm or injury?’
P3. Total paranoia score. A dimensionalmeasurewas constructed by
selecting ﬁfteen paranoia-related items from the survey
assessments to approximate those of Freeman et al. (2005). We
used items 2, 3, 3a and 3b from the PSQ, relating to ideas of
persecution, conspiracy and interference. From the SCID-II, we
used items 2, 3, 4, 6, 10, 25, 26, 27, 28, 33 and 35 (e.g. ‘Do you
spend a lot of timewondering if you can trust your friends or the
people you work with?’, ‘When you are out in public and see
people talking, do you often feel that they are talking about
you?’). The included items were chosen a priori, and progressed
in content from mistrust through reference to persecution.
The occurrence of hallucinations was assessed by the PSQ item
5, ‘Over the past year, have there been times whenyou heard or saw
things that other people couldn’t?’
The presence of anxiety, worry, depression and irritability were
assessed using the CIS-R (Lewis et al., 1992). For the mediation
analysis, computed symptom count scores varying between 0 and 4
were used (DVJ12, DVI11, DVG11, DVE11). A similar computed
symptom count (DVD11) was used for insomnia symptoms in this
mediation analysis. The questions in the survey on drug use are
taken from the U.S. ECA study (Eaton and Kessler, 1985) and self-
completed on a computer. In the current study the only drug
variable examined was cannabis use in the past year (No/Yes).
2.3. Analysis
The main analyses were carried out using the Stata 10.1 survey
data analysis commands, as these provide robust conﬁdence limits
for the analysis of datasets of complex structure (StataCorp, 2008).
Analyses were performed using data weighted to take account of
the complex survey design (in particular, the fact only one person
per household was sampled) and of non-response, in order to
ensure that the results were representative of the British household
population aged 16e74 as a whole. Full details of the weighting
procedures are available online in the technical report (Singleton
et al., 2001b). Logistic and linear regressions were used to test
associations of insomnia and paranoia.
The secondary analysis was an examination of the mediation of
the relationship between insomnia and paranoia. A model with
emotion and cannabis use as potential mediators was assessed
using a series of linear and logistic regression models (accounting
for the complex survey design). Mediation is a hypothesised causal
chain in which an independent variable X affects a mediating
variable Y, which in turn affects the outcome variable Z (Baron and
Kenny, 1986; MacKinnon, 2008). If the intervening mediator Y
explains the correlation between X and Z, we have a full media-
tional model. If X still has an effect on Z after including themediator
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mediation analysis was performed in four steps: i) a linear
regression of paranoia scores on insomnia scores was used to
estimate the total effect of insomnia ii) the proposed mediators,
emotion and cannabis use, were added as independent variables in
the ﬁrst model iii) a linear regression of emotion on insomnia was
carried out and iv) a logistic regression of cannabis use on insomnia
was performed, which enabled the indirect effects of insomnia on
paranoia to be determined. Indirect paths were assessed using the
Sobel Aroian Test (MacKinnon et al., 2002). The Sobel tests were
produced using a calculator and checked with an online software
programme (http://people.ku.edu/wpreacher/sobel/sobel.htm).
Because the cannabis use variable was dichotomous, the Sobel
Aroian test for this indirect path was modiﬁed using the method
described by MacKinnon and Dwyer (1993). The results are pre-
sented in a path diagram with regression coefﬁcients and 95%
conﬁdence intervals. A single emotion variable was created for the
mediation analysis by performing a weighted principal axis factor
analysis using the four correlated variables depression, worry,
anxiety and irritability. The factor analysis was carried out in SPSS
(2006) 15.0. It could not be performed using the complex survey
design, but the scores derived from separate factor analyses within
each area correlated almost perfectly (r ¼ 0.99). The meditational
regression analyses were also repeated using the four emotion
variables individually as possible mediators to examine the size of
their effects.3. Results
3.1. Presence of insomnia and paranoia
Sleep difﬁculties were present in 3380 participants (weighted
38.0%), insomnia of at least moderate severity in 1120 participants
(weighted 11.9%), and chronic insomnia in 623 participants
(weighted 6.6%). The number of individuals endorsing the item
‘Have there been times when you felt that people were deliberately
acting to harm you or your interests?’ was 809 (weighted 9.0%).
Individuals endorsing the item ‘Have there been times you felt that
a group of peoplewas plotting to cause you serious harm or injury?’
numbered 146 (weighted 1.6%). The mean paranoia score was 2.48
(SD¼ 2.86, minimum¼ 0, maximum¼ 14). Information concerning
insomnia and paranoia by sex and age is presented in Table 1.
Women had higher rates of insomnia, whereas there were fewTable 1
Associations of insomnia and paranoia with sex and age.
Independent variable Dependent variable Parameter coding (weighted percent
positively on dependent variable)
Sex P1 Male (8.8%)
Female (9.4%)
P2 Male (1.7%)
Female (1.3%)
P3 Male
Female
I1 Male (35.0%)
Female (44.0%)
I2 Male (10.8%)
Female (14.2%)
I3 Male (6.0%)
Female (8.0%)
Age P1 Age
P2 Age
P3 Age
I1 Age
I2 Age
I3 Agesigniﬁcant sex differences in paranoia. Insomnia increased with
age, while paranoia decreased with age. For instance, in the
youngest age group (16e25, n ¼ 907) 1.9% endorsed the paranoia
item P2 and 9.2% reported insomnia (I2), whereas in the oldest age
bracket (65e74, n ¼ 1268) 0.7% endorsed the paranoia item P2 and
14.1% reported insomnia (all percentages weighted).
3.2. Association between insomnia and paranoia
There were strong associations between all the insomnia and
paranoia variables (see Table 2). For instance, sleep difﬁculties in
the past month were associated with 2.30 times the likelihood of
endorsing the item ‘Have there been times when you felt that
people were deliberately acting to harm you or your interests?’.
Chronic insomnia increased almost ﬁvefold the likelihood of
endorsing the item ‘Have there been times you felt that a group of
people was plotting to cause you serious harm or injury?’. The
associations became stronger as the severity of insomnia increased,
and also as the severity of the content of the paranoid thoughts
increased. In linear regressions, the paranoia dimensional score
(P3) was signiﬁcantly associated with sleep difﬁculties, b¼ 1.41, p<
0.001, insomnia, b¼ 1.72, p< 0.001, and chronic insomnia, b¼ 2.23,
p < 0.001. These linear regressions altered little when controlling
for age and sex; the paranoia dimensional score (P3) remained
signiﬁcantly associated with sleep difﬁculties, b ¼ 1.44, p < 0.001,
insomnia, b ¼ 1.77, p < 0.001, and chronic insomnia, b ¼ 2.33, p <
0.001. All the associations between sleep difﬁculties and paranoid
ideation remained highly signiﬁcant (p  0.001) when the analyses
were repeated controlling for the presence of hallucinations.
Similarly all the associations between sleep difﬁculties and para-
noia ideation remained highly signiﬁcant (p < 0.001) when
participants with probable diagnoses of psychosis and participants
who had used cannabis in the past year were removed from the
analyses.
3.3. Explanatory analysis
Symptom counts for paranoia (P3), insomnia, anxiety, worry,
depression, and irritability were used for the mediation analysis.
Cannabis use in the past year was a dichotomous variable. The
paranoia and sleep symptom scores were both positively associated
with anxiety, worry, depression, irritability and cannabis use (see
Table 3). These associations remained highly signiﬁcant evenage scoring Odds ratio or regression coefﬁcient 95% C.I. p-value
0.90, 1.26 0.442
OR ¼ 1.07
0.53, 1.20 0.278
OR ¼ 0.80
0.21, 0.51 <0.001
b ¼ 0.36
1.33, 1.60 <0.001
OR ¼ 1.46
1.19, 1.58 <0.001
OR ¼ 1.37
1.13, 1.63 0.001
OR ¼ 1.35
OR ¼ 0.98 0.97, 0.98 <0.001
OR ¼ 0.98 0.97, 0.99 0.005
b ¼ 0.03 0.04, 0.03 < 0.001
OR ¼ 1.01 1.00, 1.01 <0.001
OR ¼ 1.01 1.01, 1.02 <0.001
OR ¼ 1.02 1.01, 1.02 <0.001
Table 2
Associations of paranoia and insomnia.
Unadjusted Age and sex adjusted
Odds Ratio p-value 95% C.I. Odds Ratio p-value 95% C.I.
P1 dependent variable: ‘In the past year, have there been times when you felt that people were deliberately acting to harm you or your interests?’
I1 Sleep difﬁculties 2.30 < 0.001 1.97, 2.68 2.45 <0.001 2.09, 2.87
I2 Insomnia 2.60 < 0.001 2.17, 3.12 2.83 <0.001 2.35, 3.41
I3 Chronic insomnia 2.67 < 0.001 2.12, 3.37 3.04 <0.001 2.41, 3.84
P2 dependent variable: ‘In the past year, have there been times you felt that a group of people was plotting to cause you serious harm or injury?’
I1 Sleep difﬁculties 2.33 <0.001 1.55, 3.51 2.48 <0.001 1.65, 3.73
I2 Insomnia 3.33 <0.001 2.20, 5.04 3.58 <0.001 2.37, 5.41
I3 Chronic insomnia 4.50 <0.001 2.91, 6.97 5.03 <0.001 3.24, 7.81
Emotion
Insomnia Paranoia
0.32 (0.30-0.34) 1.30 (1.19-1.40)
0.25 (0.19-0.32)
0.19
0.22
D. Freeman et al. / Journal of Psychiatric Research 44 (2010) 1021e10261024controlling for age and sex (p  0.001). A factor score was created
for the affective measures. A principal axis factor analysis extracted
one factor explaining 44.5% of the variance. All four emotion vari-
ables had loadings over 0.5 with the underling factor (Depression¼
0.66, Worry ¼ 0.74, Anxiety ¼ 0.68, Irritability ¼ 0.58), justifying
the use of factor scores as a response measure of the underlying
construct “emotion”.
The result of the mediation analysis is summarized in the path
diagram (Fig. 1). All direct paths were highly signiﬁcant (p <
0.0001). A simple linear regression showed that insomnia was
positively associated with paranoia, b ¼ 0.677, 95% C.I.:
0.611e0.743. The total effect was reduced by 62% to 0.254 when
the emotion variable was added into the model. The indirect effect
of insomnia via the emotion moderator was 0.417 (0.373e1.147),
Sobel Aroian z ¼ 18.26, p < 0.0001. There was only a small but
signiﬁcant moderating effect of cannabis use, Sobel Aroian z ¼
3.14, p ¼ 0.0017; the odds of cannabis use increased by 1.17 for
each unit increase of insomnia, and cannabis users scored an
average of 0.66 higher on the paranoia scale compared with non-
cannabis users. Consequently, adding cannabis use further reduced
the direct effect of insomnia to 0.251 (95% C.I.: 0.186e0.315), but
this is clearly a very small reduction (1%). Overall, the mediation
analysis indicates that the effect of insomnia on paranoia is
partially and predominately mediated by the emotion factor score.
Using the four emotion variables (anxiety, worry, depression,
irritability) in separate regression analysis (including cannabis use)
showed that the total effect of insomnia was reduced much less in
each case, Worry: binsomnia ¼ 0.41 (0.35e0.48), Irritability: binsomnia
¼ 0.43 (0.36e0.49), Depression: binsomnia ¼ 0.46 (0.39e0.53),
Anxiety: binsomnia ¼ 0.46 (0.40e0.53). The mediating effect of the
emotion variables was consequently smaller than using the factor
scores of the latent variable emotion, with worry having the
largest effect, then irritability, and anxiety and depression having
a similar effect.Table 3
Associations of paranoia and insomnia with affective symptoms and cannabis use.
Coefﬁcient (b) p-value L.C.I. U.C.I
Paranoia symptom count (0e15)
Anxiety 1.17 <0.001 1.06 1.28
Worry 1.01 <0.001 0.93 1.09
Depression 1.11 <0.001 1.00 1.22
Irritability 1.03 <0.001 0.95 1.11
Cannabis use 1.08 <0.001 0.74 1.41
Insomnia symptom count (0e4)
Anxiety 0.47 <0.001 0.44 0.51
Worry 0.41 <0.001 0.38 0.44
Depression 0.49 <0.001 0.45 0.53
Irritability 0.38 <0.001 0.35 0.40
Cannabis use 0.23 <0.001 0.12 0.344. Discussion
Analysis of this large dataset provides substantive replication
of the association between insomnia and paranoia. Whether the
difﬁculty in falling or staying asleep was mild or severe, the
association with paranoia remained; likewise, whether the para-
noid thought was of mild or severe content, the association with
insomnia was maintained. The task now turns towards estab-
lishing the nature of the association. The most plausible rela-
tionship is that sleep difﬁculties and paranoid fears maintain each
other in a circular relationship. However it is also possible that
paranoid fears simply lead to withdrawal, inactivity, and rumi-
nation that disrupts sleep patterns, or that a third (unidentiﬁed)
factor explains the association. The most valuable test would be
to evaluate the effects of well-established insomnia interventions
(e.g. Espie, 2006; Harvey et al., 2007; Freeman and Freeman,
2010) for patients with persecutory delusions and sleep distur-
bance. This research method has been termed an ‘interventionist
causal model approach’ (Woodward, 2003; Kendler and Campbell,
2009).
Putative factors underlying the insomnia and paranoia associ-
ation were also examined. It was predicted that emotional
processes would (partly) explain the relationship. Sleep distur-
bance produces anxiety, depression and irritability, all factorsCannabis use
0.66 (0.37-0.95)0.16 (0.09-0.23)
OR: 1.17 (1.10-1.26)
0.007
Indirect paths:
Insomnia-Emotion-Paranoia: b=0.417 (0.373-1.147), z=18.26,p<0.0001
Insomnia-Cannabis use-Paranoia: standardised b=0.01(0.004-0.017), z=3.14, p=0.0017
Fig. 1. The mediation model. The arrows reﬂect hypothesised relationships between
the variables. Regression coefﬁcients (95% conﬁdence intervals) are shown next to each
path. Explained variance of the respective regressions are presented on the top right of
the box of the endogenous variables. Nagelkerke’s pseudo R2 and odds ratios (OR) are
presented for the logistic regression of cannabis use on insomnia. Only a standardised
effect estimate could be presented for the indirect path with the binary mediator
cannabis use.
D. Freeman et al. / Journal of Psychiatric Research 44 (2010) 1021e1026 1025linked to paranoia; worry also contributes to the occurrence of
insomnia (e.g. Nelson and Harvey, 2002) and paranoia (e.g. Startup
et al., 2007). In this large dataset the association between
insomnia and paranoia was partially, though substantially,
accounted for by the affective symptoms. This is consistent with
the earlier study (Freeman et al., 2009). However explanatory or
meditational relationships are clearly much better tested in
longitudinal designs, which are now called for in this area. It also
needs to be kept in mind that the overlap between the distinct
experiences of paranoia and insomnia is partial, as further evi-
denced by their opposite relationships to age. In addition to
testing an emotional route from insomnia to paranoia, the role of
anomalous perceptual experiences requires examination. Sleep
deprivation has long been noted to produce temporary psychotic-
like experiences (Luby et al., 1960; West et al., 1962), while
internal anomalous experiences are considered a key factor in the
occurrence of delusions (Maher, 1988; Freeman et al., 2008b). The
mediational role found in the current study for cannabis use,
which causes anomalies of experience, is supportive of such
a route. More broadly, the results of the path analysis are consis-
tent with a burgeoning empirical and theoretical literature indi-
cating a close connection between paranoia and negative affect
(e.g. Freeman, 2007; Thewissen et al., 2008; Lincoln et al., 2008).
The presence of worry, depression, irritability and anxiety were all
strongly associated with paranoid ideation. Paranoid experience
has a large affective component. Work translating this knowledge
into targeted treatments has already begun (Freeman et al., 2008a;
Foster et al., 2010).
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